Literature DB >> 9641453

Surgical margins and prognostic factors in patients with thick (>4mm) primary melanoma.

K M Heaton1, J J Sussman, J E Gershenwald, J E Lee, D S Reintgen, P F Mansfield, M I Ross.   

Abstract

BACKGROUND: Randomized trials have demonstrated the efficacy of 1- and 2-cm excision margins for thin and intermediate-thickness melanomas, respectively. The optimal margin of excision for thick melanomas is still unknown, however. We evaluated whether the margins used for intermediate-thickness melanomas can be applied safely to thicker lesions.
METHODS: The charts of 278 patients with thick primary melanomas treated between 1985 and 1996 were retrospectively reviewed. Patients with distant metastases at presentation or with follow-up less than 6 months were excluded. Median follow-up was 27 months. Known melanoma prognostic factors and excision margins were evaluated for their impact on local recurrence (LR), disease-free survival (DFS), and overall survival (OS).
RESULTS: Median tumor thickness was 6.0 mm, and 57% were ulcerated. At presentation, 201 patients (72%) were node negative and 77 (28%) were node positive (palpable or occult). The 5-year OS and DFS rates were 55% and 30%, respectively. The LR rate for all patients was 12%. Although nodal status, thickness, and ulceration were significantly associated with OS by multivariate analysis, neither LR nor excisional margin (<2 cm vs. >2 cm) significantly affected DFS or OS in these patients.
CONCLUSIONS: Because margins of excision greater than 2 cm do not improve LR, DFS, or OS compared to a margin of 2 cm or less, a 2-cm margin of excision is adequate for patients with thick melanoma. Because nodal status is a significant prognostic factor in these patients, staging by sentinel node biopsy should be considered in patients with thick melanomas and clinically negative nodal basins to allow proper entry and stratification in adjuvant therapy trials.

Entities:  

Mesh:

Year:  1998        PMID: 9641453     DOI: 10.1007/bf02303495

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  20 in total

1.  [Comment on the contribution by A. Hauschild et al.: "Safety margins in excision of primary malignant melanoma"].

Authors:  M Möhrle; H Breuninger
Journal:  Hautarzt       Date:  2002-04       Impact factor: 0.751

Review 2.  The role of radiation therapy in the management of cutaneous melanoma.

Authors:  Charlene E Kan; David B Mansur
Journal:  Melanoma Manag       Date:  2016-02-24

3.  Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas < or =2 mm thick.

Authors:  J Gregory McKinnon; Emma C Starritt; Richard A Scolyer; William H McCarthy; John F Thompson
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

Review 4.  Primary Melanoma: from History to Actual Debates.

Authors:  Alessandro A E Testori; Stephanie A Blankenstein; Alexander C J van Akkooi
Journal:  Curr Oncol Rep       Date:  2019-12-19       Impact factor: 5.075

5.  Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institution.

Authors:  Torsten Hinz; Hojjat Ahmadzadehfar; Anja Wierzbicki; Tobias Hoeller; Joerg Wenzel; Hans-J Biersack; Thomas Bieber; Monika-H Schmid-Wendtner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-05-23       Impact factor: 9.236

Review 6.  Treatment strategy for cutaneous malignant melanoma.

Authors:  Arata Tsutsumida; Hiroshi Furukawa; Yuhei Yamamoto; Tsuneki Sugihara
Journal:  Int J Clin Oncol       Date:  2005-10       Impact factor: 3.402

Review 7.  [Malignant melanoma. Diagnosis and therapy].

Authors:  E S Schultz; G Schuler
Journal:  HNO       Date:  2005-11       Impact factor: 1.284

Review 8.  Intermediate- and high-risk melanoma.

Authors:  Sanjiv S Agarwala
Journal:  Curr Treat Options Oncol       Date:  2002-06

9.  Thick melanoma: prognostic value of positive sentinel nodes.

Authors:  Lenka Vermeeren; Fred W C van der Ent; Prapto S H Sastrowijoto; Karel W E Hulsewé
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

Review 10.  Surgery and radiotherapy in the treatment of cutaneous melanoma.

Authors:  A Testori; P Rutkowski; J Marsden; L Bastholt; V Chiarion-Sileni; A Hauschild; A M M Eggermont
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.